Assignee
GENELUX CORP
US17 patents
Top patents by PatentIndex Score
US8021662B2Sep 20, 2011
Microorganisms for therapy
GENELUX CORP64 citations99
US7754221B2Jul 13, 2010
Microorganisms for therapy
GENELUX CORP132 citations99
US7662398B2Feb 16, 2010
Microorganisms for therapy
GENELUX CORP113 citations99
US7588771B2Sep 15, 2009
Microorganisms for therapy
GENELUX CORP124 citations99
US7588767B2Sep 15, 2009
Microorganisms for therapy
GENELUX CORP148 citations99
US8052968B2Nov 8, 2011
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
GENELUX CORP64 citations97
US7820184B2Oct 26, 2010
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
GENELUX CORP119 citations97
US7763420B2Jul 27, 2010
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
GENELUX CORP233 citations97
US8357486B2Jan 22, 2013
Methods and compositions for detection of bacteria and treatment of diseases and disorders
GENELUX CORP40 citations93
US9492534B2Nov 15, 2016
Microorganisms for therapy
GENELUX CORP20 citations92
US8343509B2Jan 1, 2013
Methods and compositions for detection of bacteria and treatment of diseases and disorders
GENELUX CORP16 citations91
US9944903B2Apr 17, 2018
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
GENELUX CORP5 citations83
US10238700B2Mar 26, 2019
Oncolytic virus adjunct therapy with agents that increase virus infectivity
GENELUX CORP12 citations82
US10851350B1Dec 1, 2020
Bioreactor production of virus from adherent cells
GENELUX CORP8 citations76
US10463730B2Nov 5, 2019
Microorganisms for therapy
GENELUX CORP1 citations73
US10584317B2Mar 10, 2020
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
GENELUX CORP1 citations72
US12338464B2Jun 24, 2025
Clonal strains of attenuated vaccinia viruses and methods of use thereof
GENELUX CORP0 citations61